Terje Risberg

2.1k citations

52 papers · 1.6k indexed · h-index 23

Impact in

Complementary and alternative medicine top 0.5%
- Complementary and Alternative Medicine Studies
- Herbal Medicine Research Studies
Oncology top 5%
- Cancer Cells and Metastasis

Papers in ⓘ

Complementary and alternative medicine 16
- Complementary and Alternative Medicine Studies 16
Family Practice 3

Co-authors: E. Wist (11 shared papers)Jan Norum (6 shared papers)S. Kaasa (6 shared papers)Erik A. Wist (8 shared papers)Eiliv Lund (4 shared papers)Tom Wilsgaard (5 shared papers)Bjørn Østenstad (8 shared papers)Per Eystein Lønning (11 shared papers)
Journals: European Journal of Cancer (9 papers)Journal of Clinical Oncology (6 papers)Acta Oncologica (6 papers)BMC Cancer (2 papers)Annals of Oncology (2 papers)
Partner nations: Norway United States United Kingdom

In The Last Decade

Terje Risberg

50 papers receiving 1.6k citations

Peers

Countries citing papers authored by Terje Risberg

Since Specialization

Citations

This map shows the geographic impact of Terje Risberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terje Risberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terje Risberg more than expected).

Fields of papers citing papers by Terje Risberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terje Risberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terje Risberg. The network helps show where Terje Risberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Terje Risberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Terje Risberg Line = papers co-authored together Terje Risberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Diagnostic delay causes more psychological distress in female than in male cancer patients. PubMed ·Terje Risberg, Sveinung Wergeland Sørbye, Jan Norum, Erik A. Wist	1996	128
2	Cancer patients use of nonproven therapy: a 5-year follow-up study. Journal of Clinical Oncology ·Terje Risberg, Eiliv Lund, E. Wist, S. Kaasa, Tom Wilsgaard	1998	116
3	Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study European Journal of Cancer ·Jürgen Geisler, Per Eystein Lønning, Lars Erik Krag, Erik Løkkevik, Terje Risberg, Anne Irene Hagen, Ellen Schlichting, Ernst A. Lien, Erik Snorre Øfjord, Geir Egil Eide, Anna Polli, E. Di Salle, Jolanda Paolini	2006	84
4	Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel PLoS ONE ·Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Gudbrand Skjønsberg, Turid Aas, Ellen Schlichting, Hans E. Fjøsne, Arne Nysted, Johan R. Lillehaug, Per Eystein Lønning	2011	81
5	CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer PLoS ONE ·Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Elisabet O. Berge, Terje Risberg, Ingvil Mjaaland, Lovise Mæhle, Lars Engebretsen, Johan R. Lillehaug, Per Eystein Lønning	2008	75
6	Knowledge of and attitudes toward complementary and alternative therapies European Journal of Cancer ·Terje Risberg, Arne Kolstad, Yngve Bremnes, Harald Holte, E. Wist, Olav Mella, Olbjørn Klepp, Tom Wilsgaard, Barrie R. Cassileth	2004	71
7	Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes BMC Cancer ·Trygve Lofterød, Elin Mortensen, Hawa Nalwoga, Tom Wilsgaard, Hanne Frydenberg, Terje Risberg, Anne Elise Eggen, Anne McTiernan, Sura Aziz, Erik A. Wist, Andreas Stensvold, Jon B. Reitan, Lars A. Akslen, Inger Thune	2018	66
8	Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer Journal of Clinical Oncology ·Bjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk, Gro Wiedswang, Kjetil Weyde, Terje Risberg, Christian Kersten, Ingvil Mjaaland, Lise Vindi, H Sommer, Anna Barbro Sætersdal, M.C. Rypdal, Cecilie Bendigtsen Schirmer, Erik A. Wist, Elin Borgen	2014	66
9	Medical students’ cognitive and affective attitudes towards learning and using communication skills – a nationwide cross-sectional study Medical Teacher ·Tor Anvik, Hilde Grimstad, Anders Bærheim, Ole Bernt Fasmer, Tore Gude, Per Hjortdahl, Are Holen, Terje Risberg, Per Vaglum	2008	61
10	The use of non-proven therapy among patients treated in norwegian oncological departments. A cross-sectional national multicentre study European Journal of Cancer ·Terje Risberg, Eiliv Lund, E. Wist, Olav Dahl, Stein Sundstrøm, O. K. Andersen, S. Kaasa	1995	61
11	Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer Breast Cancer Research ·Stian Knappskog, Ranjan Chrisanthar, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Beryl Leirvaag, Hrvoje Miletić, Per Eystein Lønning	2012	58
12	Does use of alternative medicine predict survival from cancer? European Journal of Cancer ·Terje Risberg, Andrew J. Vickers, Roy M. Bremnes, E. Wist, S. Kaasa, Barrie R. Cassileth	2003	56
13	Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival Breast Cancer Research ·Randi R. Mathiesen, Elin Borgen, Anne Renolen, Erik Løkkevik, Jahn M. Nesland, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Gunnar Kvalheim, Per Eystein Lønning, Bjørn Naume	2012	54
14	Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway European Journal of Cancer ·Terje Risberg, S. Kaasa, E. Wist, H Melsom	1997	50
15	Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer Acta Oncologica ·Erik A. Wist, H Sommer, Bjørn Østenstad, Terje Risberg, Yngve Bremnes, Ingvild Mjaaland	2004	50
16	Assessing medical students' attitudes towards learning communication skills – which components of attitudes do we measure? BMC Medical Education ·Tor Anvik, Tore Gude, Hilde Grimstad, Anders Bærheim, Ole Bernt Fasmer, Per Hjortdahl, Are Holen, Terje Risberg, Per Vaglum	2007	47
17	A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis Annals of Oncology ·Jan Norum, Terje Risberg, Jan Abel Olsen	2005	46
18	Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival Breast Cancer Research and Treatment ·Hanne Frydenberg, Inger Thune, Trygve Lofterød, E. Mortensen, Anne Elise Eggen, Terje Risberg, E. Wist, Vidar G. Flote, A-S Furberg, Tom Wilsgaard, Lars A. Akslen, Anne McTiernan	2016	38
19	Use Of Non-Proven Therapies: Differences In Attitudes Between Norwegian Patients With Non-Malignant Disease And Patients Suffering From Cancer Acta Oncologica ·Terje Risberg, Eiliv Lund, Erik Wist	1995	38
20	Curriculum factors influencing knowledge of communication skills among medical students BMC Medical Education ·Anders Bærheim, Per Hjortdahl, Are Holen, Tor Anvik, Ole Bernt Fasmer, Hilde Grimstad, Tore Gude, Terje Risberg, Per Vaglum	2007	26

About Terje Risberg

Terje Risberg is a scholar working on Complementary and alternative medicine, Family Practice, Oncology, Cancer Research and Complementary and Manual Therapy, having authored 52 papers that have together received 1.6k indexed citations. Recurring topics across this work include Complementary and Alternative Medicine Studies (16 papers), Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (6 papers), Patient-Provider Communication in Healthcare (6 papers), Palliative Care and End-of-Life Issues (6 papers), Childhood Cancer Survivors' Quality of Life (6 papers), Innovations in Medical Education (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Complementary and alternative medicine (435 citations), Oncology (695 citations), Cancer Research (345 citations), Complementary and Manual Therapy (31 citations) and Family Practice (25 citations). Terje Risberg has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include E. Wist, Jan Norum, S. Kaasa, Erik A. Wist, Eiliv Lund, Tom Wilsgaard, Bjørn Østenstad, Per Eystein Lønning, Sveinung Wergeland Sørbye and Erik Løkkevik. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Acta Oncologica, BMC Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact